In a recent episode of Soha Ali Khan’s YouTube podcast 'All About Her', actor Bhumi Pednekkar clarified that she has not used any weigh-loss drugs or injectables to lose over 40kgs of weight and credited her transformation to a balanced lifestyle.

The Dum Laga Ke Haisha star told Khan, "People have even asked me if I’ve had a rib removed. What about the fact that I’ve put 10 years into working out and eating right? In Delhi, women straight up come to me and ask, ‘Aapne bhi Ozempic ya Mounjaro liya hai?’

"I know enough people who have taken Ozempic and genuinely needed that medical assistance, so I will never judge anyone for it. But the fact is, I lost 40 kg and more without injectables.”

Pednekkar, 36, went on to also express annoyance over the rumors of her weight loss and noted that her battle against dengue in 2023 forced her to lose 12kgs.

"So basically, for this other character, I lost a lot of weight. I was in hospital recovering from dengue. I lost 12 kg and half my hair. The pain you go through is unmatched. It was Diwali and people were bursting crackers, while I had a splitting headache until I reached the hospital," she said.

How did Pednekkar lose weight?

For her workouts, she likes to mix things up with different workouts such as Pilates, running, strength training and weight training and completes nearly 8,000 steps on average every day.

What Are Ozempic and Mounjaro?

Ozempic (semaglutide) is a prescription injectable GLP-1 medication primarily approved for adults with Type 2 diabetes to manage blood sugar levels. However, the drug has gained immense popularity among those trying to lose weight as it can reduce hunger and help people feel full for longer, which forces the body to burn fat deposits to stay functional.

In clinical trials, people with obesity using semaglutide have shown to lose an average of about 15% of their body weight over 68 weeks. Most people begin to see noticeable results within 8 to 12 weeks of taking the drug.

The official price in India for a once-weekly Ozempic injection pen ranges from approximately ₹8,800 for the 0.25 mg dose to around ₹11,175 for the 1 mg dose per month. Insurance coverage is generally inconsistent for weight loss indications.

Similarly to Ozempic, Mounjaro mimics two natural gut hormones, GLP-1 and GIP, to regulate blood sugar, reduce appetite, slow digestion and provide the body with a feeling of fullness, leading to reduced calorie intake.

Clinical trials have shown that participants using Mounjaro along with lifestyle changes can lose up to 15-22% of their body weight over the span of 72 weeks.

Eli Lilly launched Mounjaro in India in March 2025 in the form of vials and released KwikPen versions of the drug later in August 2025. Monthly costs for KwikPens range from approximately ₹14,000 to ₹27,500.

Common side effects of both weigh-loss drugs include gastrointestinal issues, nausea, vomiting, diarrhea and constipation. More serious but rare side effects can include pancreatitis and gallbladder issues.

A meningitis outbreak in Kent University is now treated as a national incident, after two people have died, one of them being the student of the university. Students have been urged to get vaccines and take antibiotics as health officials are dealing with the "unprecedented" and "explosive" outbreak.

As per the UK Health Security Agency (UKHSA), 15 cases have been reported and all of them have lead to hospital admission. Cases are also expected to rise due to the incubation period of infection to when the symptoms start to appear. The incubation period is from two to 14 days.

A report by Sky News notes that around 5,000 students in the university halls in Kent will be offered the meningitis B or (menB) vaccine in the coming days. Four schools across the county have also confirmed cases with hundreds of people being offered antibiotics.

Read: Meningitis Outbreak: University of Kent Student Among Two Who Died of the ‘Invasive’ Disease

Quickest-growing Meningitis Outbreak

As per experts, many of whom are affected had attended Club Chemistry in Cantebury between 5 to 7 March. UKHSA chief executive Susan Hopkins said the outbreak "looks like a super-spreader" event with "ongoing spread" through universities' halls of residence. She added: "There will have been some parties particularly around this, so there will have been lots of social mixing. I can't yet say where the initial infection came from, how it's got into this cohort, and why it's created such an explosive amount of infections."

She further said that in her 35 years working in medicine, healthcare, and hospitals, "This is the most cases I've ever seen in a single weekend with this type of infection". She added: "It is the explosive nature that is unprecedented here - the number of cases in such a short space of time." She also remarked that this was the "quickest-growing outbreak" she has ever seen in her career.

Fighting For Jabs

According to The Guardian report, parents are contacting pharmacies in an "increasingly desperate" effort to get their children vaccinated against meningitis after the outbreak in the university was reported. The surge in vaccination demand has led to the stocks running so low that many pharmacies are unable to get hold of supplies from wholesalers.

A snap poll recorded that almost nine out of 10 pharmacies, which makes it 87 per cent, reported a dramatic rise in requests from concerned parents to get a child or children vaccinated, as per the National Pharmacy Association (NPA).

Read: Kent Uni Meningitis Outbreak Caused By Less-Targeted Strain B

Parents were paying £200 or more per child for a vaccine that protects against meningitis B, the strain of meningococcal bacteria involved in the outbreak. For example, Boots is charging £220 for the two jabs needed.

A pharmacy owner in Berkshire told The Guardian, “I have received about 30 or 40 calls in two hours from people wanting to book their entire families for vaccinations. They are worried. They are getting agitated.”

NPA chair, Olivier Picard told The Guardian that the demand was "far exceeding supply", which has forced pharmacies to "manage constrained levels of supply" and tell anxious parents that they cannot immunize their children.

A deadly meningitis outbreak in Kent has claimed two young lives and left several others seriously ill, prompting health authorities to urgently warn students and young people in the area.

According to reports, the outbreak involves invasive meningitis, a severe infection that spreads quickly and can become life threatening within hours. One of the victims was a student at the University of Kent, while the other was a Year 13 pupil from Faversham. Most of the affected individuals are between 18 and 21 years old, and several are university students.

Health officials say at least 11 people from the Canterbury area have been hospitalized and are currently receiving treatment.

The UK Health Security Agency (UKHSA) has begun contacting more than 30,000 students, staff members, and their families to inform them about the outbreak and the precautions being taken.

Read: Meningitis Outbreak: University of Kent Student Among Two Who Died of the ‘Invasive’ Disease

Strain B Identified As The Cause

Government scientists have now confirmed that the outbreak is caused by meningococcal strain B, a type of bacteria that many young people have not been vaccinated against.

Gayatri Amirthalingam, deputy director of immunization and vaccine preventable diseases at the UKHSA, said laboratory testing identified the strain responsible for the cluster of infections.

She explained that teenagers in the UK usually receive a meningococcal vaccine around the age of 13 or 14, but that vaccine protects against strains A, C, W, and Y, not strain B.

This means many teenagers and young adults remain vulnerable unless they received the meningitis B vaccine privately.

Why Many Young People Are Not Vaccinated

The meningitis B vaccine was introduced into the UK’s National Health Service routine immunization schedule for babies in 2015.

As a result, people born before 2015 would not have received the vaccine through the public programme. Some may have chosen to get it privately, but many did not.

Private vaccination can cost between £100 and £120 per dose in the UK, and a full course generally requires two doses.

Experts say this gap in vaccination coverage may partly explain why university-age students are susceptible during outbreaks.

Antibiotics Being Offered As Preventive Measure

Health authorities are urging anyone who may have been exposed to the infection to take preventive antibiotics immediately. UKHSA has specifically advised people who visited Club Chemistry in Canterbury between 5 and 7 March to come forward for antibiotic treatment as a precaution.

Officials say taking antibiotics quickly can help stop the bacteria from developing into disease and also prevent it from spreading to others. Amirthalingam reassured students that those who have received antibiotics can safely travel home and be around family members.

Can Sharing Vapes Spread The Infection?

The disease spreads mainly through close contact, including activities where saliva is shared. Amirthalingam noted that sharing vapes can be one possible route of transmission, although it is not the only one.

Experts say anything that goes into the mouth, including drinks, cigarettes, or vapes, can potentially pass bacteria from one person to another.

Because meningococcal bacteria can live in the throat and nose, close social contact among students often increases the risk during outbreaks.

What Is Meningitis?

Meningitis is an infection that causes inflammation of the meninges, the protective membranes surrounding the brain and spinal cord.

The illness is most often caused by bacterial or viral infections, although fungal and other causes are also possible.

Symptoms can include fever, headache, stiff neck, confusion, and sensitivity to light. In severe cases, bacterial meningitis can lead to hearing loss, neurological complications, or death if treatment is delayed.

Doctors stress that early recognition and immediate medical care are critical because the condition can worsen rapidly within a few hours.

"God asks no man whether he will accept life. That is not the choice. You must take it. The only choice is how."

This is what Justice JB Pardiwala said, quoting Henry Ward Beecher to allow India's first ever passive euthanasia for Harish Rana. AIIMS Delhi has now started protocols to implement the Supreme Court verdict for Harish Rana's passive euthanasia. Sources and several reports have mentioned that the process could take two to three weeks.

How Is AIIMS Delhi Preparing For Passive Euthanasia?

A specialized team headed by professor and head of the department of anesthesia and palliative medicine, Dr Seema Mishra, has been constituted to implement the process. The team comprises doctors from departments of neurosurgery, onco-anesthesia, and palliative medicine, and psychiatry.

“The process generally involves withholding or withdrawing the nutritional support gradually while ensuring adequate pain relief. The patient is given palliative sedation so that he or she is not in distress. Life support measures such as artificial nutrition, oxygen and medications are slowly withdrawn. The aim is not to prolong nor hasten death,” Dr Sushma Bhatnagar, former head of the department of onco-anaesthesia, pain and palliative care, AIIMS-Delhi.

Harish Rana Update

A video from Rana's home in Ghaziabad showed that relatives were offering prayers and a member of the Brahma Kumaris put a 'tilak' on his forehead. She said, "Sabko maaf karte hue, sabse maafi mange hue, so jaao...theek hai." Which loosely translates to: Forgiving everyone and asking forgiveness from everyone. Now sleep. It's okay.

The Brahma Kumari seen in the video was Sister Lovely from Mohan Nagar Seva Kendra in Ghaziabad. Komal, who is also a member of Brahma Kumaris based in Mount Abu, told this to news agency Press Trust of India (PTI). "She is following a ritual with the words that mean he (Harish) leave the world in a happy state, seeking and giving forgiveness...it is part of a meditative chant that comforts the soul and eases the entire process of soul merging with the sublime," she told PTI.

According to Komal, alongside medical consultations, the family also sought spiritual guidance as they prepared for the inevitable after the Supreme Court’s directions.

Read: Harish Rana Case Brings Spotlight On How Passive Euthanasia Has Evolved Over The Years

Harish Rana's Passive Euthanasia

The Supreme Court of India, in a landmark judgment allowed 32-year-old Harish Rana, who had been living in a vegetative state for last 13 years, the right to die. This means, that the apex court allowed passive euthanasia for Rana. The bench comprising Justice JB Pardiwala an Justice KV Vishwanathan allowed the withdrawal of life support of Rana, who has been in a coma and kept alive on tubes for breathing and nutrition after he sustained severe head injuries following a fall from a building in 2013 in Chandigarh.

The judgment is a win, however, Ashok, Rana's father said that his feelings are mixed. "As a father, this is extremely painful. But on humanitarian grounds, this is the best we can do for my son." He continued, "It is just not a matter of my son, but there are many others in such a state in the country. I think it is the grace of God who guided the Supreme Court judges... I am happy that with this judgments, many others may find a way."